Effects of Anti-NMDAR Autoantibodies on Synaptic Plasticity
Author Information
Author(s): Day Charlotte, Silva John-Paul, Munro Rebecca, Mullier Brice, André Véronique Marie, Wolff Christian, Stephens Gary J., Bithell Angela
Primary Institution: University of Reading
Hypothesis
Peptide-purified anti-NMDAR autoantibodies inhibit long-term synaptic plasticity in the hippocampus.
Conclusion
Peptide-purified anti-NMDAR autoantibodies prevent the induction of long-term potentiation in brain slices, suggesting a mechanism for synaptic dysfunction in neuropsychiatric disorders.
Supporting Evidence
- Peptide-purified anti-NMDAR antibodies showed specificity for GluN1 immunization peptides.
- These antibodies inhibited long-term potentiation in ex vivo brain slices.
- Anti-NMDAR antibodies had no clear effect on isolated NMDARs in an oocyte expression system.
- Functional effects were determined using multi-electrode arrays to measure synaptic activity.
Takeaway
This study found that certain antibodies in the body can stop brain cells from working together properly, which might be linked to mental health issues.
Methodology
The study used peptide immunization to generate antibodies, which were then purified and tested for their effects on long-term potentiation in hippocampal brain slices.
Potential Biases
Potential bias due to the use of specific antibody purification methods that may not capture the full range of antibody effects.
Limitations
The study primarily focused on in vitro models, which may not fully replicate in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website